Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001140361-21-006730

Chairman & CEO acquired 165,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCHADE CHRISTIAN S Chairman & CEO 2021-02-25 Grant or award +77,000 77,160 D
SCHADE CHRISTIAN S Chairman & CEO 2021-02-25 Grant or award +88,500 176,660 D
Derivatives
SCHADE CHRISTIAN S Chairman & CEO 2021-02-25 Grant or award · Stock Option (right to Buy) +329,000 329,000 D
Loading xslF345X03/form4.xml…